PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Change in liver fat between groups were in the same direction as for the primary analysis and statistically significant for individuals with T2D (not for prediabetes), those without NAFLD (not NAFLD) as well as for individuals with the I148M PNPLA3 CC-genotype (not CG/GG).